Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy.
about
Oncolytic Virotherapy: A Contest between Apples and Oranges.Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Partners in Crime: Combining Oncolytic Viroimmunotherapy with Other Therapies.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
P2860
Q39230055-E06AF1F8-FD05-4811-B656-C91C898AB511Q39387174-FE483CD0-DCA6-4CFC-B425-5340CD18E6EDQ45324769-4B1CFF16-5D7B-4963-A673-96C08916F342Q45865962-A7FC7936-7B57-4B5B-AA3E-EEF5A45C02D4Q47120629-1CA5B472-1435-4FCE-8724-DE2EC0C55D76Q47365404-9A99004C-5477-4160-9085-D1F0E415C35DQ52674215-7B9B483D-10A3-4153-AB58-A0E1DF1C544C
P2860
Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibitory Receptors Induced b ...... Improving Treatment Efficacy.
@en
type
label
Inhibitory Receptors Induced b ...... Improving Treatment Efficacy.
@en
altLabel
Inhibitory Receptors Induced b ...... r Improving Treatment Efficacy
@en
prefLabel
Inhibitory Receptors Induced b ...... Improving Treatment Efficacy.
@en
P2093
P2860
P921
P1154
2-s2.0-85017023093
P1433
P1476
Inhibitory Receptors Induced b ...... Improving Treatment Efficacy.
@en
P2093
Amanda Huff
Christopher B Driscoll
Jill Thompson
Jose S Pulido
Karishma R Rajani
Kevin G Shim
Laura Evgin
Matthew Schuelke
Richard G Vile
Shane Zaidi
P2860
P304
P356
10.1016/J.YMTHE.2017.01.023
P407
P577
2017-02-22T00:00:00Z